169324 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Intracellular protein regulatory factors and their receptors, e.g. including ion channels
High throughput screening of ion channels
#1202Formation of neuromuscular junctions in a co-culture comprising rat muscle cells overlayered with differentiated human spinal cord stem cells in a serum free medium
#1203MITOCHONDRIA KATP ION CHANNEL AS A DRUG TARGET FOR PREVENTING LIVER DISEASES AND METHODS TO SCREEN MITOCHONDRIA KATP MODULATORS
#1204Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator
#1205Methods and compositions for the diagnosis and treatment of diabetes
#1206Insecticidal compounds and methods for selection thereof
#1207Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#1208HUMAN SALTY TASTE RECEPTOR AND METHODS OF MODULATING SALTY TASTE PERCEPTION
#1209High Throughput Assays for TRPM7
#1210Mutations associated with cystic fibrosis
#1211Fluorescent substrates for neurotransmitter transporters
#1212TRP/HIS exchange and kynurenin induced TRP transport
#1213SIRT1 Modulation of Adipogenesis and Adipose Function
#1214Methods and kits for the diagnosis of RyR1-related diseases
#1215Assay for analysis of free drug in samples
#1216Compositions and methods for modulating skin pigmentation
#1217Ivermectin antagonizes ethanol inhibition in P2X4 receptors
#1218USE OF ERYTHROPOIETIN TO DEVELOP SMALL MOLECULE INHIBITORS OF JANUS KINASE-2
#1219Methods of screening heteromeric T1R2/T1R3 receptors which modulate sweet taste signaling
#1220Polypeptides and use thereof
#1221Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits
#1222TREATMENT OF TH17-MEDIATED AUTOIMMUNE DISEASE VIA INHIBITION OF STAT 3
#1223METHODS FOR THE CLASSIFICATION AND DIAGNOSIS OF SCOLIOSIS THROUGH THE USE OF GI PROTEIN RECEPTOR
#1224DIAGNOSIS AND TREATMENT OF BACK PAIN
#1225DETERMINATION OF RENIN-PRORENIN RECEPTOR ACTIVITY
#1226STAT3 and TYK2 as drug targets for neurodegenerative diseases
#1227Cell, method and kit for conducting an assay for neutralizing antibodies
#1228MODULATION OF BONE DEVELOPMENT
#1229NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB
#1230CANINE TRANSIENT RECEPTOR POTENTIAL V2 (CTRPV2) AND METHODS OF SCREENING FOR TRPV2 CHANNEL MODULATORS
#1231P2X7 epitopes
#1232METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#1233Method of Identifying Agents that Promote Axonal Development
#1234BRIDGED SECONDARY AMINES AND USE THEREOF AS IAP BIR DOMAIN BINDING COMPOUNDS
#1235Compositions and methods for treatment
#1236Compositions and methods for treatment
#1237CIDEA MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#1238LYMPHANGIOGENESIS-PROMOTING AGENTS
#1239Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof
#1240Crystal structure of the CCZ-LZ domain of NEMO
#1241Zinc binding compounds and their method of use
#1242PROBE FOR VISUALIZING NEURAL ACTIVITY
#1243Compositions and Methods for Increasing Bone Mineralization
#1244Methods to identify modulators of the interaction between dextromethorphan and the bitter taste receptor TAS2R46
#1245NEURTURIN RECEPTOR
#1246Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
#1247Anti-alpha2 integrin antibodies and their uses
#1248EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use
#1249METHODS OF TREATING KIDNEY DISEASE
#1250Method for identifying immune response modulators
#1251FLUORESCENCE BASED ASSAY TO DETECT SODIUM/CALCIUM EXCHANGER (NCX ) "REVERSE MODE" MODULATING COMPOUNDS
#1252Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases
#1253Screening for compounds having immunosuppressant activity by testing impact on leukocyte-specific calcium fluxes
#1254FLUORESCENCE BASED ASSAY TO DETECT SODIUM/CALCIUM EXCHANGER "FORWARD MODE" MODULATING COMPOUNDS
#1255Sodium channel protein type III α-subunit splice variant
#1256Serotonin transporter gene and treatment of alcoholism
#1257Methods and Kits for Detecting Congenital Stationary Night Blindness and Selecting Different Coat Patterns
#1258Kokumi-imparting agent
#1259Non-functional P2Xreceptor
#1260Use of biological photoreceptors as directly light-activated ion channels
#1261Method for Preclinical Testing of Immunomodulatory Drugs
#1262Methods of identifying compounds that bind TANGO240
#1263Endoglin antibodies
#1264Methods of modulating and identifying agents that modulate intracellular calcium
#1265Peptides and uses thereof
#1266Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats
#1267Single domain TDF-related compounds and analogs thereof for use in treating a tissue differentiation factor related disorder
#1268Yeast cells expressing TAR DNA-binding protein 43 and uses therefor
#1269Mass spectrometric methods and products
#1270Method for screening olfactory sensibility inhibitor
#1271High throughput screen
#1272Mutant proteins and methods for selecting them
#1273METHODS OF MONITORING THE MODULATION OF THE KINASE ACTIVITY OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USES OF SAID METHOD
#1274METHODS OF MODULATING IMMUNE RESPONSES BY MODULATING TIM-1, TIM-2 AND TIM-4 FUNCTION
#1275BILAYERS
#1276Methods of Reducing the Production of Reactive Oxygen Species and Methods of Screening or Identifying Compounds and Compositions that Reduce the Production of Reactive Oxygen Species
#1277ANTIVIRALS THAT TARGET TRANSPORTERS, CARRIERS, AND ION CHANNELS
#1278Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32)
#1279Dietary Calcium for Reducing the Production of Reactive Oxygen Species
#1280Nucleic acids that encode sodium channel
#1281Methods and compositions related to TR4 ligand
#1282Antibodies specific for ZNT8
#1283Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
#1284Treating cardiovascular disease with TRPC3 channel protein
#1285SCAFFOLD FOR COMPOSITE BIOMIMETIC MEMBRANE
#1286TRPC6 involved in glomerulonephritis
#1287Oligopeptidic compounds and uses thereof
#1288Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#1289Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels
#1290Histidine related compounds for identifying and blocking amyloid beta ion channels
#1291Crystal structure of human JAK3 kinase domain complex and binding pockets thereof
#1292Method of screening for compounds that can be used for the treatment of respiratory conditions
#1293Methods for identification of bone anabolic agents
#1294KCNN3 AS DIAGNOSTIC AND THERAPEUTIC TARGET FOR NEURODEGENERATIVE DISEASES
#1295Identification of toxin ligands
#1296METHOD AND DEVICE FOR STUDYING TRANSPORT OF AN AGENT ACROSS A BILAYER MEMBRANE IN BIOANALYTICAL SENSOR APPLICATIONS
#1297Assays for non-apoptotic cell death and uses thereof
#1298Cystic fibrosis transmembrane conductance regulator gene mutations
#1299SYSTEMS AND METHODS FOR STUDYING INFLUENZA
#1300Modulators of ATP-binding cassette transporters
#1301PHOTOSWITCH-ENABLED ION CHANNEL ASSAY SYSTEM
#1302Method for identifying compounds for treatment of pain
#1303Long wavelength fluorogenic intracellular ion indicators that are well retained in the cytosol
#1304Methods for use with BAFF antagonists
#1305COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#1306Marks as modifiers of the p53 pathway and methods of use
#1307STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#1308Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside
#1309Compositions and methods for treating inflammation
#1310Ribosome Structure and Protein Synthesis Inhibitors
#1311COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
#1312COMPOSITIONS AND METHODS FOR MODULATING CELLULAR MEMBRANE-MEDIATED INTRACELLULAR SIGNAL TRANSDUCTION
#1313Cell lines expressing ENaC and methods using them
#1314PHOSPHOPROTEOMIC EVALUATION OF DIABETES AND OBESITY
#1315NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM
#1316Molecular adaptors
#1317Methods for diagnosing interstitial cystitis via nuclear localization of beta-catenin
#1318Identification of the hepcidin binding site on ferroportin
#1319METHODS OF REGULATING APOPTOSIS
#1320COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX
#1321Method for screening of cell-protecting agent
#1322HADHs as Modifiers of the p21 Pathway and Methods of Use
#1323DEVICE FOR MEASUREMENT OF TRANSPORT SYSTEMS
#1324Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
#1325POLYNUCLEOTIDES ENCODING ACETYLCHOLINE-GATED CHLORIDE CHANNEL SUBUNITS OF CAENORHABDITIS ELEGANS
#1326Voltage gated calcium channel β-subunit anchoring regulator protein and uses thereof
#1327Process for making modulators of cystic fibrosis transmembrane conductance regulator
#1328Stable cell lines expressing hERG
#1329EGR1 MODULATORS FOR THE TREATMENT OF ALOPECIA
#1330Dielectric spectroscopy assays for screening of ion channel ligands
#1331Biological marker for inflammation
#1332SCREENING METHODS
#1333High Throughput Screening Assay for the TRPM5 Ion Channel
#1334Screening Assay for Inhibitors of TRPA1 Activation by a Lower Alkyl Phenol
#1335METHODS AND KITS FOR IDENTIFICATION OF ANTI-EXCITOTOXIC COMPOUNDS
#1336Cancer diagnostic kit and cancer diagnostic method
#1337MEASUREMENT OF NEURAL ACTIVITY
#1338Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same
#1339Assay for detection of transient intracellular CA
#1340METHOD FOR SCREENING FOR SELECTIVE MODULATOR OF THE NF-KB PATHWAY ACTIVATION
#1341Cholesterol-Regulating Complex of SIRT1 and LXR and Methods of Use
#1342Delivery of a light-activated cation channel into the brain of a subject
#1343IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL
#1344Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#1345METHOD FOR THE SCREENING PROTEASOME OF ACTIVITY-MODULATING AGENTS AND MEANS FOR CARRYIING OUT SAID METHOD
#1346Artificial lipid membrane forming method and artificial lipid membrane forming apparatus
#1347METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION
#1348METHOD OF IDENTIFYING AGENTS WHICH MODULATE THE ACTIVITY OF CALCIUM-ACTIVATED CHLORIDE CHANNEL
#1349POLYMORPHIC LENGTH OF FOXE1 ALANINE STRETCH AND GENETIC SUSCEPTIBILITY TO THYROID DYSGENESIS
#1350TDF-related compounds and analogs thereof, analogs and bioactive fragments
#1351Blood-brain barrier targeting anti-bodies
#1352Ribosome structure and protein synthesis inhibitors
#1353Method for using division arrested cells in screening assays
#1354Grating-based sensor combining label-free binding detection and fluorescence amplification and readout system for sensor
#1355Anti-system ASC amino acid transporter 2 (ASCT2) antibody
#1356METHOD FOR IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF AGENTS WHICH MODULATE ION CHANNEL ACTIVITY
#1357Methods for identifying inhibitors of solute transporters
#1358COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY
#1359Arrays of biological membranes and methods and use thereof
#1360Methods and Devices for Diagnosis of Appendicitis
#1361GALK1S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE
#1362Monitoring and manipulating cellular transmembrane potentials using nanostructures
#1363Protein Phosphorylation By Basophillic Serine/Threonine Kinases
#1364METHODS OF STRATIFYING ADOLESCENT IDIOPATHIC SCOLIOSIS, ISOLATED NUCLEIC ACID MOLECULES FOR USE IN SAME AND KITS USING SAME
#1365Stabilized low affinity conformation of integrins for drug discovery
#1366Methods for screening modulators of SLC17-type anion transport activity
#1367Transgenic mice expressing humanized VEGF
#1368p16 MEDIATED REGULATION OF NMDA RECEPTORS
#1369ACETYLYCHOLINE GATED ION CHANNEL CHAPERONS AND METHODS OF USING THE SAME
#1370Reagents for the detection of protein phosphorylation in signaling pathways
#1371SCDs as modifiers of the p53 pathway and methods of use
#1372Continuous Assay Method for Measuring Receptor- and Ion Channel-Mediated Calcium Response and Subsequent Gene Expression
#1373Compositions and methods for increasing bone mineralization
#1374FLUORESCENCE-BASED ASSAY FOR DETECTING COMPOUNDS FOR MODULATING THE SODIUM-CALCIUM EXCHANGER (NCX) IN "FORWARD MODE"
#1375GENOMIC SEQUENCING USING MODIFIED PROTEIN PORES AND IONIC LIQUIDS
#1376System for optical stimulation of target cells
#1377Regulation of protein synthesis
#1378Inhibiting cyclin D polypeptides
#1379NUCLEOTIDE SEQUENCE ENCODING A MODULATOR OF NF-KB
#1380GRATING BASED SENSOR COMBINING LABEL-FREE BINDING DETECTION AND FLUORESNCE AMPLIFICATION AND READOUT SYSTEM FOR SENSOR
#1381Targeting NCchannel for organ protection following ischemic episode
#1382METHODS OF DIAGNOSIS OF SPINAL MUSCULAR ATROPHY AND TREATMENTS THEREOF
#1383Compound containing farnesyl diphosphate for modulating TRPV3 function and use thereof
#1384Modulation of NR2F6 and methods and uses thereof
#1385Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
#1386Screening method for prokinetic agent
#1387Radio-frequency ion channel probe
#1388CDC6S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE
#1389METHODS AND COMPOSITIONS FOR TREATING CERVICAL CANCER
#1390Polypeptides that bind membrane proteins
#1391Tissue analysis and kits therefor
#1392Monitoring and manipulating cellular transmembrane potentials using nanostructures
#1393Modulators of cystic fibrosis transmembrane conductance regulator
#1394Blood biomarkers for bone fracture and cartilage injury
#1395METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT
#1396KIT FOR DECIDING DEGREE OF MALIGNANCY IN PROSTATE CANCER AND METHOD OF USING THE SAME
#1397Mutation Implicated in Abnormality of Cardiac Sodium Channel Function
#1398METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#1399METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITIS
#1400Molecular Targets for Treatment of Learning and Memory Dysfunction
#1401MANIPULATION OF NEURONAL ION CHANNELS
#1402Cancer biomarkers
#1403Remedy for diabetes
#1404IRF-5 haplotypes in systemic lupus erythematosus
#1405Compositions and methods for treatment of eye disorders
#1406COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#1407Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
#1408Jasmonate based assays for identifying compounds that selectively inhibit mitochondrial bound hexokinases
#1409Methods for Treatment and Diagnosis of Pulmonary Diseases Based on the Expression of SERCA2 Protein
#1410PLGF, FLT1 AND ENDOGLIN FOR DIAGNOSING ANGIOGENIC STATUS IN CORONARY ARTERY DISEASE
#1411Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
#1412Ion channel assay methods
#1413Dual variable domain immunoglobulins and uses thereof
#1414T1R taste receptors and genes encoding same
#1415METHOD OF DETERMINING THE RISK OF SCOLIOSIS
#1416Cloned glucagon-like peptide-2 receptors
#1417Methods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
#1418Degranulation inhibitor
#1419PROTEIN KINASE C ZETA AS A DRUG TARGET FOR ARTHRITIS AND OTHER INFLAMMATORY DISEASES
#1420Compositions and methods for promoting or inhibiting angiogenesis
#1421METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#1422Modulators
#1423Formation of bilayers of amphipathic molecules
#1424COMPOSITIONS AND METHODS FOR MODULATING CELLULAR MEMBRANE-MEDIATED INTRACELLULAR SIGNAL TRANSDUCTION
#1425Method for achieving desired glial growth factor 2 plasma levels
#1426Method for identifying modulators of the NRF2-KEAP1-AREP pathway
#1427Light-inducible and rhythmically expressed genes and method for screening substances that affect an internal clock system
#1428Method for Identifying an Agent that Modulates Arginine Transport in a Chondrocyte
#1429Cholesterol loaded insect cell membranes as test proteins
#1430Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)
#1431COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#1432METHOD FOR DETERMINING TRANSPORT ACTIVITY OF A TRANSPORT PROTEIN
#1433Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells
#1434Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system
#1435Cytochrome c acetylation
#1436Assays and enhancers of the human delta ENaC sodium channel
#1437Mass spectrometric methods and products
#1438Treatment of insulin resistance by administering an acid-sensing ion channel 3 inhibitor
#1439Tracers for monitoring the activity of sodium/glucose cotransporters in health and disease
#1440Method of evaluating metabolism of the eye
#1441COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
#1442Method and apparatus for measuring analyte transport across barriers using x-ray fluorescence
#1443Method for inhibiting expression of a protein in a hepatocyte
#1444Mutations in ion channel proteins associated with sudden cardiac death
#1445Methods of modulating and identifying agents that modulate intracellular calcium
#1446CALCIUM-ACTIVATED CHLORIDE CHANNEL AND METHODS OF USE THEREOF
#1447Nogo-B receptor antagonists
#1448R-RAS activity in vascular regulation
#1449IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics
#1450Modulators of ATP-binding cassette transporters
#1451Phospho-specific anti-Pax3 antibodies
#1452METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING SEIZURES BY MODULATING ACID-SENSING ION CHANNEL ACTIVITY
#1453Method for Detecting a Biochemical Interaction
#1454MRP2 efflux pathway prognostic method
#1455Calcium-sensing receptor 2 (CaR2) and methods for using
#1456Stochastic sensing through covalent interactions
#1457Compositions And Methods For Identifying Modulars Of TRPV2
#1458METHOD FOR IDENTIFYING MODULATORS OF THE ACTIVITY OF ION-CHANNELS RECEPTORS
#1459Human T1R2 taste receptor nucleic acids and cells containing these nucleic acids
#1460COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION
#1461Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
#1462Radiotracers for imaging P-glycoprotein function
#1463Sodium channel protein type III α-subunit splice variant
#1464High-Throughput Cell-Based CFTR Assay
#1465Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
#1466System and method for execution of a secured environment initialization instruction
#1467Reagents for the detection of protein phosphorylation in signaling pathways
#1468Modulators of the transporter ABCD3 for treating acne or hyperseborrhea
#1469Ion channel assay methods
#1470Fluorescence polarization hERG assay
#1471Antihuman α9 integrin antibody and use of the same
#1472COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
#1473COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH
#1474Modulators of scarb-1 for treating acne or hyperseborrhea
#1475Prevention and treatment of osteoarthritis
#1476Kokumi-imparting agent
#1477METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE DETECTION OF MOLECULES
#1478UHRF1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#1479Modulators of ATP-binding cassette transporters
#1480COMPOSITIONS AND METHODS FOR MODULATING CELLULAR MEMBRANE-MEDIATED INTRACELLULAR SIGNAL TRANSDUCTION
#1481Grating-based sensor combining label-free binding detection and fluorescence amplification and readout system for sensor
#1482COMPOSITIONS AND METHODS FOR INHIBITING G PROTEIN SIGNALING
#1483Heteroaryl derivatives as CFTR modulators
#1484Methods for identifying compounds that modulate T1R1/T1R3 umami taste receptors
#1485Method of revealing a biological process using a FRET measurement
#1486Injectable Combination Therapy for Eye Disorders
#1487Rage/Diaphanous Interaction and Related Compositions and Methods
#1488Methods and compositions for the diagnosis and treatment of schizophrenia
#1489ERCC1 EXPRESSION IN PREDICTING RESPONSE FOR CANCER CHEMOTHERAPY
#1490MODULATION OF BNE DEVELOPMENT
#1491Soluble CLCA-1 and antagonists to CLCA-1
#1492Quinoxaline derivatives as antitumor agents
#1493Identification methods for ergothioneine transporter modulators and therapeutic uses thereof
#1494Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone, and/or vasopressin production or release
#1495Methods of screening for TRPM4b modulators
#1496Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
#1497Neuregulin variants and methods of screening and using thereof
#1498Methods for identifying insulin mimetics
#1499Reagents for the detection of tyrosine phosphorylation in brain ischemia signaling pathways
#1500Use of the ENDO-180 gene and polypeptide for diagnosis and treatment